Review Articles (434 articles)
Explore this paper's citation graph
Summary
This review contains specific recommendations for the identification and management of most important complications such as the bleeding disorder, APL differentiation syndrome, QT prolongation and other ATRA- and ATO-related toxicities, as well as for molecular assessment of response to treatment.
- Published
- 2008-01-01
- Cited by
- 2,949
- References
- 0
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1088077
References
No references recorded for this paper.
Cited by
- Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia
- Machine Learning Based Analysis of DNA Methylation Patterns in Pediatric Acute Leukemia
- Differentiation therapy of leukemia: 3 decades of development.
- Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.
- Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia: 10-year results of the Japan Adult Leukemia Study Group APL97 study
- IDH1 and IDH2 mutations in myeloid neoplasms – Novel paradigms and clinical implications
- Utilization of molecular phenotypes to detect relapse and optimize the management of acute promyelocytic leukemia.
- Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapse
- "Boldness be my friend" (Shakespeare; Cymbeline).
- Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era
- Copper levels in patients with hematological malignancies.
- Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.
- The Role of Therapeutic Leukapheresis in Hyperleukocytotic AML
- Clinical Characteristics and Outcomes in Patients with Acute Promyelocytic Leukaemia and Hyperleucocytosis
- Complex karyotype, older age, and reduced first‐line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long‐term follow‐up
- Prognostic significance of the BAALC gene expression in adult patients with acute myeloid leukemia: A meta-analysis.
- Targeting of cell metabolism in human acute myeloid leukemia – more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?
- FLT3‐ITD mutations do not impact the outcome of patients allografted with partial T‐cell depleted grafts for AML with normal cytogenetics in first complete remission
- Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS
Related papers
No related papers recorded.